Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2010

01-07-2010

Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B

Authors: Yufu Ye, Xiaojun Xie, Jiwei Yu, Lin Zhou, Haiyang Xie, Guoping Jiang, Xiaobo Yu, Wenjin Zhang, Jian Wu, Shusen Zheng

Published in: Journal of Clinical Immunology | Issue 4/2010

Login to get access

Abstract

Background

Local production of cytokines within the liver may play a pivotal role in the regulation of pathophysiological processes during inflammation. CD4+ T cells are regarded as the most prolific cytokine producers. The purpose of this study was to quantify intrahepatic expression of Th1, Th2, Th17, and Treg-associated cytokines or transcription factors in patients with acute hepatitis B or chronic hepatitis B (CHB) and to analyze their relative roles in the promotion and regulation of hepatitis B virus (HBV)-associated liver diseases.

Methods

Distribution and expression of IL-17, IFN-γ, IL-4, Foxp3, and other cytokines in liver tissues were detected by immunohistochemistry and real-time quantitative PCR. Patients with hepatitis B were compared with patients with chronic hepatitis C, primary biliary cirrhosis, alcoholic liver cirrhosis, and healthy controls.

Results

The frequencies of intrahepatic IL-17 and IFN-γ-producing cells in patients with HBV-associated liver dysfunction were much higher than that of IL-4 and Foxp3-positive cells. The level of the IL-17/IFN-γ-positive cell ratio of patients with Child–Pugh class C (1.57 ± 0.09) was much higher than that of patients with Child–Pugh class B (1.00 ± 0.02) or A (0.93 ± 0.05). There are more IL-17-producing cells than IFN-γ-producing cells accumulating in the liver with severe hepatocellular damage. Liver IL-17-producing cell infiltration was positively associated with the grade of liver inflammation in CHB and positively correlated to intrahepatic IL-8 expression (r = 0.801, p < 0.01) or neutrophil infiltration (r = 0.917, p < 0.01).

Conclusions

These results suggest that the balance of effector CD4+ Th responses (Th17 and Th1 responses) and regulatory response is an important element of immune regulation. Inappropriate, excessive, and non-specific Th17 and Th1 effector responses may be involved in the pathogenesis of HBV-associated liver inflammation and hepatocellular damage. Th17 response, especially, may exacerbate the inflammatory processes leading to liver failure. IL-17-mediating liver neutrophil recruitment via induction of IL-8 may be one potential mechanism of liver injury in patients with hepatitis B. An improved understanding of the factors that influence the differentiation and function of these cell types in vivo will be of great importance to the future development of immune therapies in HBV-associated liver disease.
Literature
1.
go back to reference Bettelli E, Carrier YJ, Gao WD, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature. 2006;441(7090):235–8.CrossRefPubMed Bettelli E, Carrier YJ, Gao WD, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature. 2006;441(7090):235–8.CrossRefPubMed
3.
5.
go back to reference Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117(3):645–52.CrossRefPubMed Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117(3):645–52.CrossRefPubMed
6.
go back to reference Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16(5–6):541–51.CrossRefPubMed Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16(5–6):541–51.CrossRefPubMed
7.
go back to reference Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Journal of Hepatology. 2007;47(4):598–607.CrossRefPubMed Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Journal of Hepatology. 2007;47(4):598–607.CrossRefPubMed
8.
go back to reference Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123–32.CrossRefPubMed Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6(11):1123–32.CrossRefPubMed
9.
go back to reference Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26(8):912–9.CrossRefPubMed Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int. 2006;26(8):912–9.CrossRefPubMed
10.
go back to reference Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485–517.CrossRefPubMed Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009;27:485–517.CrossRefPubMed
11.
go back to reference Koziel MJ. The immunopathogenesis of HBV infection. Antivir Ther. 1998;3 Suppl 3:13–24.PubMed Koziel MJ. The immunopathogenesis of HBV infection. Antivir Ther. 1998;3 Suppl 3:13–24.PubMed
12.
go back to reference Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347–52.PubMed Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347–52.PubMed
13.
go back to reference Lan RYZ, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W, et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun. 2009;32(1):43–51.CrossRefPubMed Lan RYZ, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W, et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun. 2009;32(1):43–51.CrossRefPubMed
14.
go back to reference Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49(2):646–57.CrossRefPubMed Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49(2):646–57.CrossRefPubMed
16.
go back to reference Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol. 2001;126(3):179–84.CrossRefPubMed Linden A. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol. 2001;126(3):179–84.CrossRefPubMed
17.
go back to reference Lohr HF, Weber W, Schlaak J, Goergen B, Zumbuschenfelde KHM, Gerken G. Proliferative response of CD4(+) T-cells and hepatitis-B virus clearance in chronic hepatitis with or without hepatitis -B E-minus hepatitis-B virus mutants. Hepatology. 1995;22(1):61–8.PubMed Lohr HF, Weber W, Schlaak J, Goergen B, Zumbuschenfelde KHM, Gerken G. Proliferative response of CD4(+) T-cells and hepatitis-B virus clearance in chronic hepatitis with or without hepatitis -B E-minus hepatitis-B virus mutants. Hepatology. 1995;22(1):61–8.PubMed
18.
go back to reference McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45–55.CrossRefPubMed McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S45–55.CrossRefPubMed
19.
go back to reference Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol. 1999;162(11):6503–9.PubMed Nishimura T, Ohta A. A critical role for antigen-specific Th1 cells in acute liver injury in mice. J Immunol. 1999;162(11):6503–9.PubMed
20.
go back to reference Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133–41.CrossRefPubMed Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133–41.CrossRefPubMed
21.
go back to reference Penna A, DelPrete G, Cavalli A, Bertoletti A, Delios MM, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 1997;25(4):1022–7.CrossRefPubMed Penna A, DelPrete G, Cavalli A, Bertoletti A, Delios MM, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 1997;25(4):1022–7.CrossRefPubMed
22.
go back to reference Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5(3):215–29.CrossRefPubMed Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5(3):215–29.CrossRefPubMed
23.
go back to reference Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, et al. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection. J Med Virol. 2003;71(3):376–84.CrossRefPubMed Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, et al. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection. J Med Virol. 2003;71(3):376–84.CrossRefPubMed
24.
go back to reference Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest. 1997;99(12):3025–33.CrossRefPubMed Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest. 1997;99(12):3025–33.CrossRefPubMed
25.
go back to reference Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13(2):139–45.CrossRefPubMed Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13(2):139–45.CrossRefPubMed
26.
go back to reference Takahashi H, Zeniya M, Watanabe F, Hayashi A, Hokari A, Aizawa Y, et al. Significance of intracellular Th1/Th2 cytokine analysis in chronic viral hepatitis. Hepatology. 1997;26(4):1926–6. Takahashi H, Zeniya M, Watanabe F, Hayashi A, Hokari A, Aizawa Y, et al. Significance of intracellular Th1/Th2 cytokine analysis in chronic viral hepatitis. Hepatology. 1997;26(4):1926–6.
27.
go back to reference Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87–113.CrossRefPubMed Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87–113.CrossRefPubMed
28.
go back to reference Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251–76.CrossRefPubMed Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 1995;13:251–76.CrossRefPubMed
29.
30.
go back to reference Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79(15):9369–80.CrossRefPubMed Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79(15):9369–80.CrossRefPubMed
31.
go back to reference Xiao MJ, Wang CH, Zhang JH, Li ZG, Zhao XQ, Qin ZH. IFN gamma promotes papilloma development by up-regulating Th17-associated inflammation. Cancer Res. 2009;69(5):2010–7.CrossRefPubMed Xiao MJ, Wang CH, Zhang JH, Li ZG, Zhao XQ, Qin ZH. IFN gamma promotes papilloma development by up-regulating Th17-associated inflammation. Cancer Res. 2009;69(5):2010–7.CrossRefPubMed
32.
go back to reference Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005;11(1):52–6.CrossRefPubMed Xu XW, Lu MH, Tan DM. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect. 2005;11(1):52–6.CrossRefPubMed
33.
go back to reference Yasumi Y, Takikawa Y, Endo R, Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res. 2007;37(4):248–54.CrossRefPubMed Yasumi Y, Takikawa Y, Endo R, Suzuki K. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res. 2007;37(4):248–54.CrossRefPubMed
34.
go back to reference Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, et al. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Ann Surg Oncol. 2008;15(12):3494–502.CrossRefPubMed Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, et al. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Ann Surg Oncol. 2008;15(12):3494–502.CrossRefPubMed
35.
go back to reference Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol. 2009;50(5):980–9.CrossRefPubMed Zhang JP, Yan J, Xu J, Pang XH, Chen MS, Li L, et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol. 2009;50(5):980–9.CrossRefPubMed
36.
go back to reference Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81–91.PubMed Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81–91.PubMed
Metadata
Title
Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis B
Authors
Yufu Ye
Xiaojun Xie
Jiwei Yu
Lin Zhou
Haiyang Xie
Guoping Jiang
Xiaobo Yu
Wenjin Zhang
Jian Wu
Shusen Zheng
Publication date
01-07-2010
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2010
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9416-3

Other articles of this Issue 4/2010

Journal of Clinical Immunology 4/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.